Vaccine apathy drops as turnout rises in Lagos

Despite working at the largest tertiary healthcare facility in Nigeria’s economic capital, Lagos, John still held a tight grip on his reservations about taking the COVID-19 vaccine. His primary concern like most was developing side effects from the Oxford-University-developed AstraZeneca vaccine. But he threw that behind him a week after interacting with colleagues who had been vaccinated and staying fit. Thousands of Lagos residents like John are increasingly opening up to vaccination, with some motivated by the incentive of international travel access. Those vaccinated could escape restricti…

Read More

HEDGE accordingly